Report Detail
Global Blood Pressure Disorders Drug Market Growth (Status and Outlook) 2019-2024
- RnM3574927 |
- 05 July, 2019 |
- Global |
- 150 Pages |
- LPI(LP Information) |
- Other
Blood pressure disorder drug development technology and related units
High blood pressure, also known as high blood pressure, is a condition in which arterial blood pressure continues to rise. Many factors affect blood pressure, including hormone levels in the body, water and salt levels, and kidney, nervous system and blood vessels.
Most hypertensive patients do not have any signs or symptoms even if their blood pressure readings reach dangerously high levels. Although a small number of people with early-onset hypertension may experience dizziness, dizziness, or more nosebleeds than normal, these symptoms and symptoms usually do not occur until the high blood pressure reaches a critical stage. There are currently 253 products under development.
According to this study, over the next five years the Blood Pressure Disorders Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Blood Pressure Disorders Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Blood Pressure Disorders Drug market by product type, application, key companies and key regions.
This study considers the Blood Pressure Disorders Drug value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hypertension
Hypotension
Pulmonary Hypertension
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial - Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Blood Pressure Disorders Drug market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Blood Pressure Disorders Drug market by identifying its various subsegments.
Focuses on the key global Blood Pressure Disorders Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Blood Pressure Disorders Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Blood Pressure Disorders Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Blood Pressure Disorders Drug Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Blood Pressure Disorders Drug Market Size 2014-2024
- 2.1.2 Blood Pressure Disorders Drug Market Size CAGR by Region
- 2.2 Blood Pressure Disorders Drug Segment by Type
- 2.2.1 Diuretics
- 2.2.2 Diuretics
- 2.2.3 Angiotensin Receptor Blockers (ARBs)
- 2.2.4 Others
- 2.3 Blood Pressure Disorders Drug Market Size by Type
- 2.3.1 Global Blood Pressure Disorders Drug Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type (2014-2019)
- 2.4 Blood Pressure Disorders Drug Segment by Application
- 2.4.1 Hypertension
- 2.4.2 Hypotension
- 2.4.3 Pulmonary Hypertension
- 2.5 Blood Pressure Disorders Drug Market Size by Application
- 2.5.1 Global Blood Pressure Disorders Drug Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Blood Pressure Disorders Drug Market Size Growth Rate by Application (2014-2019)
3 Global Blood Pressure Disorders Drug by Players
- 3.1 Global Blood Pressure Disorders Drug Market Size Market Share by Players
- 3.1.1 Global Blood Pressure Disorders Drug Market Size by Players (2017-2019)
- 3.1.2 Global Blood Pressure Disorders Drug Market Size Market Share by Players (2017-2019)
- 3.2 Global Blood Pressure Disorders Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Blood Pressure Disorders Drug by Regions
- 4.1 Blood Pressure Disorders Drug Market Size by Regions
- 4.2 Americas Blood Pressure Disorders Drug Market Size Growth
- 4.3 APAC Blood Pressure Disorders Drug Market Size Growth
- 4.4 Europe Blood Pressure Disorders Drug Market Size Growth
- 4.5 Middle East & Africa Blood Pressure Disorders Drug Market Size Growth
5 Americas
- 5.1 Americas Blood Pressure Disorders Drug Market Size by Countries
- 5.2 Americas Blood Pressure Disorders Drug Market Size by Type
- 5.3 Americas Blood Pressure Disorders Drug Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Blood Pressure Disorders Drug Market Size by Countries
- 6.2 APAC Blood Pressure Disorders Drug Market Size by Type
- 6.3 APAC Blood Pressure Disorders Drug Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Blood Pressure Disorders Drug by Countries
- 7.2 Europe Blood Pressure Disorders Drug Market Size by Type
- 7.3 Europe Blood Pressure Disorders Drug Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Blood Pressure Disorders Drug by Countries
- 8.2 Middle East & Africa Blood Pressure Disorders Drug Market Size by Type
- 8.3 Middle East & Africa Blood Pressure Disorders Drug Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Blood Pressure Disorders Drug Market Forecast
- 10.1 Global Blood Pressure Disorders Drug Market Size Forecast (2019-2024)
- 10.2 Global Blood Pressure Disorders Drug Forecast by Regions
- 10.2.1 Global Blood Pressure Disorders Drug Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Blood Pressure Disorders Drug Forecast by Type
- 10.8 Global Blood Pressure Disorders Drug Forecast by Application
11 Key Players Analysis
- 11.1 A1M Pharma AB
- 11.1.1 Company Details
- 11.1.2 Blood Pressure Disorders Drug Product Offered
- 11.1.3 A1M Pharma AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 A1M Pharma AB News
- 11.2 Acceleron Pharma Inc
- 11.2.1 Company Details
- 11.2.2 Blood Pressure Disorders Drug Product Offered
- 11.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Acceleron Pharma Inc News
- 11.3 Ache Laboratorios Farmaceuticos SA
- 11.3.1 Company Details
- 11.3.2 Blood Pressure Disorders Drug Product Offered
- 11.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Ache Laboratorios Farmaceuticos SA News
- 11.4 Actelion Pharmaceuticals Ltd
- 11.4.1 Company Details
- 11.4.2 Blood Pressure Disorders Drug Product Offered
- 11.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Actelion Pharmaceuticals Ltd News
- 11.5 Aerogen Ltd
- 11.5.1 Company Details
- 11.5.2 Blood Pressure Disorders Drug Product Offered
- 11.5.3 Aerogen Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Aerogen Ltd News
- 11.6 Anavex Life Sciences Corp
- 11.6.1 Company Details
- 11.6.2 Blood Pressure Disorders Drug Product Offered
- 11.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Anavex Life Sciences Corp News
- 11.7 AnGes Inc
- 11.7.1 Company Details
- 11.7.2 Blood Pressure Disorders Drug Product Offered
- 11.7.3 AnGes Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 AnGes Inc News
- 11.8 Arena Pharmaceuticals Inc
- 11.8.1 Company Details
- 11.8.2 Blood Pressure Disorders Drug Product Offered
- 11.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Arena Pharmaceuticals Inc News
- 11.9 Ascendia Pharmaceuticals LLC
- 11.9.1 Company Details
- 11.9.2 Blood Pressure Disorders Drug Product Offered
- 11.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Ascendia Pharmaceuticals LLC News
- 11.10 Ascendis Pharma A/S
- 11.10.1 Company Details
- 11.10.2 Blood Pressure Disorders Drug Product Offered
- 11.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Ascendis Pharma A/S News
- 11.11 AVEO Pharmaceuticals Inc
- 11.12 Bayer AG
- 11.13 Bial - Portela & Ca SA
- 11.14 Bioblue Technologies Inc
- 11.15 Biogen Inc
- 11.16 Biolab Farmaceutica Ltda
- 11.17 BioRestorative Therapies Inc
- 11.18 Boryung Pharmaceutical Co Ltd
- 11.19 Bristol-Myers Squibb Co
- 11.20 Camurus AB
- 11.21 Capricor Therapeutics Inc
- 11.22 Celsion Corp
- 11.23 Celtaxsys Inc
- 11.24 Chiesi Farmaceutici SpA
- 11.25 Chong Kun Dang Pharmaceutical Corp
- 11.26 Chugai Pharmaceutical Co Ltd
- 11.27 CJ HealthCare Corp
- 11.28 Complexa Inc
- 11.29 Corion Biotech Srl
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Blood Pressure Disorders Drug. Industry analysis & Market Report on Blood Pressure Disorders Drug is a syndicated market report, published as Global Blood Pressure Disorders Drug Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Blood Pressure Disorders Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
